Ligand validation:5IF8

6AX: 5-[(4-chlorophenyl)methyl]-1,3,4-oxadiazol-2-amine

6AX is a Ligand Of Interest in 5IF8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IF8_6AX_A_801	3%	44%	0.262	0.6	1.42	0.77	2	-	0	0	100%	0.45

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.